| PPR3B_RAT |
Rattus norvegicus |
|
PPR3B_RAT is differentially expressed in 32 experiments [30 up/22 dn]: 14 organism parts: kidney [0 up/2 dn], paraventricular nucleus [0 up/1 dn], ...; 3 disease states: normal [1 up/1 dn], breast cancer [1 up/0 dn], ...; 1 cell types, 11 compound treatments, 5 clinical treatments and 4 other conditions. |
| PPR3B_RAT, Ppp1r3b, Ppp1r4 |
|
ppp1r3b (Danio rerio)
PPP1R3B (Homo sapiens)
Ppp1r3b (Mus musculus)
(Compare orthologs)
|
|
|
| Protein phosphatase 1, glycogen targeting subunit, Metazoa, Putative phosphatase regulatory subunit |
|
|
| enzyme binding, glycogen granule, glycogen metabolic process, protein phosphatase type 1 complex, regulation of glycogen catabolic process |
|
|
|
Q6IN01
|
|
|
|
ENSRNOG00000011474
|
|
|
| Factor Value |
Factor |
Up/Down |
Legend: - number of studies the gene is up/down in
|
|
None
|
Compound treatment |
|
|
Kidney
|
Organism part |
|
|
Normal
|
Disease state |
|
|
None
|
Clinical treatment |
|
|
Paraventricular nucleus
|
Organism part |
|
|
Colon
|
Organism part |
|
|
Diethylstilbestrol
|
Compound treatment |
|
|
Control
|
Compound treatment |
|
|
Neurointermediate lobe
|
Organism part |
|
|
P15
|
Developmental stage |
|
|
P30
|
Developmental stage |
|
|
Clofibrate
|
Compound treatment |
|
|
Distal small intestine
|
Organism part |
|
|
Tibialis anterior skeletal mus...
|
Organism part |
|
|
Extraocular skeletal muscle
|
Organism part |
|
|
Biological replicate 3
|
Replicate |
|
|
E16
|
Developmental stage |
|
|
Breast cancer
|
Disease state |
|
|
N-methyl-N-nitrosurea
|
Compound treatment |
|
|
Instillation
|
Clinical treatment |
|
|
Inhalation
|
Clinical treatment |
|
|
Toxic compound
|
Clinical treatment |
|
|
Bisphenol A
|
Compound treatment |
|
|
Liver
|
Organism part |
|
|
Peritoneal fat
|
Organism part |
|
|
Biological replicate 2
|
Replicate |
|
|
Moderate spinal cord injury
|
Disease state |
|
|
E12.5
|
Developmental stage |
|
|
Cerebral cortex
|
Organism part |
|
|
Supraoptic nucleus
|
Organism part |
|
|
Spermatid
|
Cell type |
|
|
Proximal small intestine
|
Organism part |
|
|
Genestein
|
Compound treatment |
|
|
Technical replicate 1
|
Replicate |
|
|
P28
|
Developmental stage |
|
|
Cerebellum
|
Organism part |
|
|
N-methylformamide
|
Compound treatment |
|
|
Diethylhexylphthalate
|
Compound treatment |
|
|
Dorsal root ganglion
|
Organism part |
|
|
Single exposure
|
Protocol type |
|
|
Repeated exposure
|
Protocol type |
|
|
Trigger of ischemic preconditi...
|
Clinical treatment |
|
|
Epidermal growth factor
|
Compound treatment |
|
|
Untreated
|
Protocol type |
|
|
Spermatides
|
Target cell type |
|
|
Methylprednisolone
|
Compound treatment |
|
|
|
|
|
Processing time: 0.071 secs.